T1DM is an autoimmune-mediated disease characterized by selective destruction of insulin-producing pancreatic β-cells, resulting in the need for lifelong administration of exogenous insulin for patient survival [1], and represents 5–10% of all cases of diabetes [2, 3]. This evidence concerns the gene INS and type 1 diabetes mellitus.